IBT
NEUTRALInternational Biotechnology Trust PLC Provides Latest Factsheet and Blog Update
The investment trust has released its latest factsheet and a blog post discussing the political landscape and its potential impact on the biotech sector.
International Biotechnology
652.96GBX
0.77%
Market Cap
226.31M
Volume
1.1k
1% of avg
P/E Ratio
EPS (TTM)
N/A
Beta
N/A
Day Range
652.96p - 656.02p
52 Week Range
480.00p652.96p802.84p
652.96p
Upcoming Events
Early December 2025
Expected Annual General Meeting
High Impact Event
IBT
NEUTRALInternational Biotechnology Trust PLC Hosts Investor Event
The investment trust is hosting an online investor event to discuss the latest news and trends in the pharmaceutical and biotechnology sectors.
IBT
NEUTRALInternational Biotechnology Trust Provides Latest Factsheet and Blog
The biotechnology investment trust has released its latest factsheet and a new blog post from the portfolio managers.
IBT
NEUTRALInternational Biotechnology Trust Director Increases Shareholding
The director of the biotechnology investment trust has purchased additional shares in the company.
IBT
NEUTRALInternational Biotechnology Trust (IBT) reports strong half-year results
The investment trust has reported positive results for the half-year, with the co-managers delivering strong NAV total returns despite a negative period for the reference index.
IBT
GOODInternational Biotechnology Trust Outperforms Index in Half-Year Results
This investment trust focused on biotechnology outperformed its benchmark, delivering a 2.9% NAV total return. It benefited from strategic acquisitions and maintains an attractive 4.4% dividend yield, despite sector challenges.
IBT
NEUTRALInternational Biotechnology Trust Announces Directorate Change
The biotechnology investment trust announces the resignation of a non-executive director and chair of the audit committee.
IBT
NEUTRALInternational Biotechnology Trust Receives New Research Coverage
The investment trust receives new research coverage, providing investors with additional analysis on the company's performance and outlook.
IBT
NEUTRALIntl. Biotechnology Trust PLC: Change in Shareholding Reported
The biotechnology investment trust has reported a change in shareholding, with no further details provided.
IBT
NEUTRALInternational Biotechnology Trust Director Purchases Shares
The biotechnology company has announced a director has purchased a small number of shares.